This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Biocrates Life Sciences AG, an Austrian company that provides metabolomics assay kits and analytical services. The $525,058.55 contract is for Biocrates to perform metabolomic profiling of 3,021 human plasma samples from the Baltimore Longitudinal Study of Aging to examine the metabolic signatures underlying motor and cognitive decline related to...
This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Biocrates Life Sciences AG, doing business as Biocrates, for $293,721.48. Biocrates is a for-profit organization that provides metabolomics assay kits and services for quantitative, mass spectrometry-based metabolomics analysis to support biomedical, nutrition, and environmental health research across federal agencies including NIH, U.S. Department of...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price purchase order to Biocrates Life Sciences AG, doing business as Biocrates, for $422,572.24 to provide laboratory services for plasma samples processing. The contract has an August 9, 2021 completion date and was awarded on August 10, 2020. The contract is not set aside. Biocrates is a supplier of metabolomics assay kits and services that has received prior federal...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. government, to Biocrates Life Sciences AG, an Austrian company specializing in metabolomics assay kits, laboratory services, and targeted metabolite analysis. The contract, valued at $272,457.10, does not have a set-aside designation, indicating Biocrates competed for this award in an unrestricted manner. The contract involves the supply of Biocrates' products and...
The National Institute on Drug Abuse (NIDA) awarded a $106,704.75 firm-fixed-price purchase order to Biocrates Life Sciences AG, an Austrian company, for targeted metabolomics analyses of human brain tissue samples. This contract is not associated with a set-aside designation. Biocrates has extensive experience providing metabolomics assay kits, laboratory services, and targeted metabolite analysis capabilities to support biomedical research across federal agencies such as the NIH, USDA, and...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Eye Institute to Biocrates Life Sciences AG, an Austrian company doing business as Biocrates. The $20,500 contract is for Biocrates to provide ready-to-measure kits and laboratory services for quantitative, reproducible, and standardized mass spectrometry-based metabolomics analysis in support of biomedical, nutrition, and environmental health...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Biocrates Life Sciences AG, doing business as Biocrates, for the supply of drugs and biological materials. The $158,650.00 contract does not have a set-aside designation and is for the delivery of metabolomics assay kits, equipment, and services in support of biomedical, nutrition, and environmental health research...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Metabolon, Inc., a self-certified small disadvantaged business, for $249,825.00. The contract is for a longitudinal study of aging in mice and non-human primates, with a completion date of October 31, 2020. Metabolon provides metabolomics services and solutions to federal agencies, including the Department of Veterans Affairs,...
Metabolon, Inc. was awarded a firm fixed price purchase order valued at $249,989.74 by the National Institutes of Health's National Institute on Aging to conduct a longitudinal study of aging in mice and non-human primates. The contract was awarded under the Department of Health and Human Services and will be performed by Metabolon, Inc.'s Morrisville, North Carolina division from August 2023 through January 2024. No subcontractors or set aside designations were indicated. The National Institute...
<p>The National Institutes of Health National Institute on Aging, within the Department of Health and Human Services, awarded a $638,000 firm fixed price delivery order contract to QPS Austria GmbH. The contract is for experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. The period of performance is from June 1, 2022 through May 31, 2023, with all work to be conducted in Austria by QPS Austria GmbH as the prime contractor.</p>
This federal contract award, valued at $91,048.68, was issued by the National Institute on Aging (NIA), a civilian agency, to Biocrates Life Sciences AG, an Austrian-based for-profit organization. The contract is for the provision of targeted quantitative metabolomics assays in brain and blood samples from a rat model of cognitive aging and human induced pluripotent stem cell-derived astrocytes, neurons, and microglia. The objective is to explore metabolic changes associated with cognitive resilience during aging and identify potential drug targets. This contract was competitively awarded without a set-aside designation, indicating Biocrates' positioning in providing advanced metabolomic research technologies and services to federal agencies. Biocrates has previously secured similar federal contracts from the NIA, National Eye Institute, U.S. Department of Agriculture, and Environmental Protection Agency, ranging from $16,568 to $422,572, in support of various research initiatives.